National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

sirolimus (sir-OH-lih-mus)

 A drug used to prevent the rejection of organ and bone marrow transplants by the body. Sirolimus is an antibiotic that blocks a protein involved in cell division and inhibits the growth and function of certain T cells of the immune system that are involved in the body's rejection of foreign tissues and organs. It is a type of immunosuppressant and a type of serine/threonine kinase inhibitor. Sirolimus was previously called rapamycin. Also called Rapamune.



Previous Definitions:single nucleotide polymorphism, single-photon emission computed tomography, Singulair, siplizumab, Sipuleucel-T
Next Definitions:SIRS, SJG-136, Sjögren syndrome, SK&F106615, skeletal

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov